NeuroSense Therapeutics Announces 1-For-20 Reverse Stock Split, Effective Sept. 14
SEC. https://www.sec.gov/Archives/edgar/data/1875091/000121390026098414/ea0304823-6k_neurosense.htm
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
SEC. https://www.sec.gov/Archives/edgar/data/1875091/000121390026098414/ea0304823-6k_neurosense.htm
Analysts initiated coverage with Buy ratings on SpaceX, Securitize ; Overweight on Londian Wason.
Analysts initiated coverage: Neutral COP; Buy TLSA ($7), OXY ($73), NRSN ($8); Sell SM ($35).